title: Prostate cancer cell proliferation and angiogenesis in different obese mice models.
abstract: Obesity has been associated with increased incidence and aggressiveness of prostate cancer. Although controversial, several studies suggest that leptin could influence tumour cell growth and proliferation. The main goal of this study was to assess cellular growth of prostate adenocarcinoma cells in obese mice with different endogenous hormonal environments in what relates to leptin circulating levels and sensitivity. Four groups of mice (n = 6/group) were used, namely obese mice with congenital non-functioning leptin receptor OBR (db/db), obese mice with congenital leptin deficiency (ob/ob), mice with diet induced obesity (DIO) and normal weight C57BL/6J mice (control). All groups of mice were injected subcutaneously with 3.0 x 10(5) RM1 cells/500 microl PBS (murine prostate carcinoma androgen insensitive cells) and tumour growth and angiogenesis were evaluated 14 days after inoculation. The tumours induced in ob/ob and DIO mice were significantly larger (P < 0.001) while those induced in db/db mice were significantly smaller (P = 0.047), when compared with controls. Morphometric analysis revealed that mitotic index and Ki-67 positive nuclear density, both cell proliferation markers, were also significantly lower in the tumours of db/db mice (P < 0.001) when compared to controls. An inverse correlation was observed between leptin plasma levels and tumour weight (r = -0.642, P < 0.001), mitotic index (r = -0.646, P < 0.01) and Ki-67 positive nuclear density (r = -0.795, P < 0.001). These results suggest that high leptin concentrations are not favourable to RM1 cell growth and proliferation. On the contrary, high plasma leptin levels were associated with less cellular proliferation and angiogenesis in vivo.
authors.affiliation: Department of Anatomy and UMIB (Unit for Multidisciplinary Biomedical Research) of ICBAS, University of Porto, 4099-003 Porto, Portugal.
authors.forename: Andreia M
authors.initials: AM
authors.lastname: Ribeiro
authors.forename: Sara
authors.initials: S
authors.lastname: Andrade
authors.forename: Filipa
authors.initials: F
authors.lastname: Pinho
authors.forename: J Duarte
authors.initials: JD
authors.lastname: Monteiro
authors.forename: Madalena
authors.initials: M
authors.lastname: Costa
authors.forename: Carlos
authors.initials: C
authors.lastname: Lopes
authors.forename: Artur P
authors.initials: AP
authors.lastname: Aguas
authors.forename: Mariana P
authors.initials: MP
authors.lastname: Monteiro
mesh_terms: D000230:Adenocarcinoma / Q000098:blood supply* / Q000378:metabolism / Q000473:pathology*; D000818:Animals; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D004195:Disease Models, Animal; D007150:Immunohistochemistry; D007328:Insulin / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D019394:Ki-67 Antigen / Q000378:metabolism; D020738:Leptin / Q000097:blood / Q000172:deficiency; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008940:Mitotic Index; D009154:Mutation; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000473:pathology*; D009765:Obesity / Q000235:genetics / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D011471:Prostatic Neoplasms / Q000098:blood supply* / Q000473:pathology*; D054411:Receptors, Leptin / Q000235:genetics / Q000378:metabolism; D013997:Time Factors; D047368:Tumor Burden
chemical_list: D007328:Insulin; D019394:Ki-67 Antigen; D020738:Leptin; D054411:Receptors, Leptin; C515447:leptin receptor, mouse; D007334:Insulin-Like Growth Factor I